baha the information company

baha is a leading provider of real-time market data, financial news, technology and solutions for the financial industry. baha offers real-time data terminals for professionals, global financial market data covering over 12 million financial instruments on more than 150 exchanges, as well as 24/7 breaking news with global coverage and free web and mobile apps. From a total of around 200 real-time data providers worldwide, only Reuters 1851, Bloomberg 1981 and now baha in 2021 were named after the founder.

LABORATORIOS FARMACEUT./ ES0157261019 /

2024-06-05 12:31:17 PM	Chg. 0.00	Volume	Bid12:46:04 PM	Ask12:46:04 PM	High	Low
89.40EUR	0.00%	0 Turnover: 0.00	89.20Bid Size: 150	89.50Ask Size: 150	89.95	88.90

TeleTrader 1:12 PM UK tribunal allows $17B adtech suit against Google to go ahead

GlobeNewswire 1:05 PM Fortuna Announces Offering of Convertible Senior Notes

GlobeNewswire 1:05 PM Eldorado Gold Announces Election of Directors and Voting Results from Annual Meeting of Shareholders

GlobeNewswire 1:05 PM Y-mAbs Deepens Radiopharmaceutical Leadership with Appointment of Norman LaFrance, M.D. as Chief Dev...

Newsfile Corp 1:02 PM Agency Aurora Expands Global Reach to Empower Businesses Worldwide

GlobeNewswire 1:01 PM Ocean Biomedical (NASDAQ: OCEA) Congratulates Joint Venture Partner, Virion Therapeutics, on Positiv...

GlobeNewswire 1:00 PM SpringWorks Therapeutics to Participate in the Goldman Sachs 45th Annual Global Healthcare Conferenc...

GlobeNewswire 1:00 PM G1 Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire 1:00 PM AutoZone Vendor Summit Recognizes Contributions of Top Suppliers

TeleTrader 1:00 PM US mortgage applications fall by 5.2%

Newsfile Corp 1:00 PM American Aires Expands #airesathletes Campaign Through Agreement with Captain of NHL's Toronto Maple...

GlobeNewswire 1:00 PM Statement from Bart Demosky, Executive Vice President and CFO, Bombardier, on S&P’s Global Ratings U...

GlobeNewswire 1:00 PM SPOD Lithium Amends Property Option Agreements and Appoints a New Director

GlobeNewswire 1:00 PM ACELYRIN, INC. Announces Positive 16-week Data From its Global Phase 2b/3 Trial of Izokibep in Psori...

GlobeNewswire 1:00 PM CytoSorbents to Host its 2024 Virtual Annual Stockholders Meeting

GlobeNewswire 1:00 PM Apellis Pharmaceuticals to Host a Fireside Chat at the Goldman Sachs 45th Annual Global Healthcare C...

GlobeNewswire 1:00 PM Amplify ETFs Earns Four Nominations for With Intelligence Mutual Fund and ETF Awards

GlobeNewswire 1:00 PM Mesa Regains Compliance with NASDAQ Minimum Bid Price Requirement

GlobeNewswire 1:00 PM GeneDx Announces Patient Access Program to Expand Access to Exome Testing for Pediatric Epilepsy Pat...

GlobeNewswire 1:00 PM Altimmune Presents Data at EASL International Liver Congress™ 2024 Supporting the Disease Modifying ...

GlobeNewswire 1:00 PM PyroGenesis Clears Final Requirement to Becoming Approved Titanium Powder Supplier to Global Aerospa...

GlobeNewswire 1:00 PM Cibus to Participate in Upcoming June Investor Events

GlobeNewswire 1:00 PM Lantronix IoT Solution Enables Digital Retail Shelf Signage Solution for HY-LINE Group

GlobeNewswire 1:00 PM Amicus Therapeutics to Present at the Goldman Sachs 45th Annual Global Healthcare Conference

GlobeNewswire 1:00 PM Krystal Biotech to Present at Goldman Sachs 45th Annual Global Healthcare Conference

LABORATORIOS FARMACEUT./ ES0157261019 /

If you wish to receive reply to your feedback, please provide your email address.